Evaluation of thiamine effect on heart failure
Not Applicable
- Conditions
- Cardiac failure.Heart failure
- Registration Number
- IRCT201702152622N3
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Inclusion criteria :CABG candidates; ejection fraction>40%; age >18 years old.
Exclusion criteria: emergency operation; accompanying surgery; history of recent alcohol abuse; EF>40%; recent consumption of group B vitamins and Cefteriaxone; off pump CABG; sensitivity to group B vitamins .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood lactate level. Timepoint: 0, 6, 18, and 24 hours after intervention. Method of measurement: Bloos sample lab test.
- Secondary Outcome Measures
Name Time Method Intubation time. Timepoint: During hospitalization. Method of measurement: clinical assessment.;Duration of hospitalization. Timepoint: During hospitalization. Method of measurement: Clinical Assessment.;Length of stay in ICU. Timepoint: During hospitalization. Method of measurement: Clinical Assessment.;One-month mortality. Timepoint: 1 mo after ICU admision. Method of measurement: Clinical Assessment.